Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
This is a compounded prescription injection that combines tadalafil, oxytocin and PT-141 (bremelanotide) in one dose. It targets three pathways at once: blood flow from tadalafil, bonding from oxytocin, and brain-level desire from PT-141. It is meant for patients whose sexual difficulties span more than one area or who have not responded well to single-ingredient treatment. No single-ingredient product covers all three mechanisms, but the combination is not FDA-approved as a unit, PT-141 is off-label outside premenopausal women with HSDD, and there is little published evidence on the trio used together.
In stockReturn policy
This is a compounded injectable that combines three active ingredients in one dose: tadalafil, oxytocin and PT-141 (bremelanotide). Each targets a different part of sexual function. Tadalafil acts on blood flow, oxytocin on emotional bonding, and PT-141 on brain-level desire.
It is a rapid-dissolving injectable and takes a multi-pathway approach in a single injection. It is intended for patients whose challenges span more than one area, or who haven't fully responded to single-mechanism approaches.
It is physician-prescribed and compounded by licensed US pharmacies. The PT-141 component is off-label for use outside of premenopausal women with HSDD.